Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Neurology|April 18, 2007
Treatment of pediatric multiple sclerosis and variantsD Pohl, E Waubant, B Banwell, et al.
AJNR. American Journal of Neuroradiology|August 4, 2012
Diffusion tensor analysis of pediatric multiple sclerosis and clinically isolated syndromesM S Vishwas, B C Healy, R Pienaar, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 30, 2015
Demographic and clinical features of neuromyelitis optica: A reviewL Pandit, N Asgari, M Apiwattanakul, et al.
The Journal of Clinical Investigation|March 10, 2001
CD28-independent induction of experimental autoimmune encephalomyelitisT Chitnis, N Najafian, K A Abdallah, et al.
Environment International|September 23, 2017
Exposure to particulate matter air pollution and risk of multiple sclerosis in two large cohorts of US nursesN Palacios, K L Munger, K C Fitzgerald, et al.
The Journal of Clinical Investigation|September 7, 2001
Effect of targeted disruption of STAT4 and STAT6 on the induction of experimental autoimmune encephalomyelitisT Chitnis, N Najafian, C Benou, et al.
Multiple Sclerosis and Related Disorders|April 17, 2015
Elevated relapse rates in pediatric compared to adult MS persist for at least 6 yearsL A Benson, B C Healy, M P Gorman, et al.
Multiple Sclerosis and Related Disorders|March 20, 2015
Patients report worse MS symptoms after menopause: findings from an online cohortR Bove, B C Healy, E Secor, et al.
The Journal of Clinical Investigation|April 20, 2000
Role of passive T-cell death in chronic experimental autoimmune encephalomyelitisS Issazadeh, K Abdallah, T Chitnis, et al.
Multiple Sclerosis and Related Disorders|January 6, 2018
Predictors of hematological abnormalities in multiple sclerosis patients treated with fingolimod and dimethyl fumarate and impact of treatment switch on lymphocyte and leukocyte countM Baharnoori, C T Gonzalez, A Chua, et al.
Pageof 4